As the Australian share market opens amidst global geopolitical tensions, investors are keenly watching how these developments might influence local indices. In such a climate, identifying stocks with strong financial health becomes crucial, especially when considering penny stocks—an area that continues to intrigue investors despite its somewhat outdated label. These smaller or less-established companies can offer significant value and growth potential when backed by solid fundamentals; we'll highlight three such promising penny stocks on the ASX.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating West African Resources (ASX:WAF) A$3.38 A$3.86B ★★★★★★ Fenix Resources (ASX:FEX) A$0.35 A$267.74M ★★★★☆☆ LaserBond (ASX:LBL) A$0.585 A$69.15M ★★★★★★ Regal Funds Management (ASX:RPL) A$2.66 A$974.64M ★★★★★★ Praemium (ASX:PPS) A$0.69 A$336.36M ★★★★★★ Ora Banda Mining (ASX:OBM) A$1.325 A$2.55B ★★★★★★ EDU Holdings (ASX:EDU) A$0.865 A$108.08M ★★★★★★ Integrated Research (ASX:IRI) A$0.30 A$54.18M ★★★★★★ CTI Logistics (ASX:CLX) A$1.88 A$147.57M ★★★★☆☆ Cogstate (ASX:CGS) A$2.40 A$410M ★★★★★★

Click here to see the full list of 391 stocks from our ASX Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

Cogstate

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Cogstate Limited is a neuroscience solutions company that focuses on creating, validating, and commercializing digital brain health assessments globally, with a market cap of A$410 million.

Operations: Cogstate generates revenue primarily from its Clinical Trials segment, which includes precision recruitment tools and research, amounting to $53.59 million, and its Healthcare segment, including sports-related services, contributing $2.48 million.

Market Cap: A$410M

Cogstate Limited's financial health is marked by a strong balance sheet, with short-term assets of $51 million exceeding both its long-term and short-term liabilities. The company is debt-free, enhancing its financial stability. Recent earnings growth has been robust at 46.7%, outpacing the industry average of 18.9%. Cogstate reported revenue of US$26.92 million for the half-year ending December 2025, reflecting a consistent upward trend in profitability with net income rising to US$4.53 million. Management anticipates further revenue growth supported by a solid sales pipeline and record contracted revenues for the second half of fiscal year 2026.

Click here and access our complete financial health analysis report to understand the dynamics of Cogstate. Assess Cogstate's future earnings estimates with our detailed growth reports.

Story Continues

ASX:CGS Financial Position Analysis as at Apr 2026

Harvey Norman Holdings

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Harvey Norman Holdings Limited operates in the integrated retail, franchise, property, and digital system sectors with a market capitalization of A$6.12 billion.

Operations: The company's revenue is derived from its retail operations across various regions, including A$982.13 million in New Zealand, A$790.99 million in Singapore & Malaysia, A$786.78 million in Ireland, A$257.21 million in Slovenia & Croatia, and A$51.70 million in the United Kingdom, along with non-franchised retail contributing A$234.02 million.

Market Cap: A$6.12B

Harvey Norman Holdings Limited shows a mixed financial picture. Despite a market capitalization of A$6.12 billion, its earnings have grown by 29.8% over the past year, outpacing its five-year average decline of 14.8% annually. The company's net profit margin improved to 18.1%, and its debt is well covered by operating cash flow at 61.6%. However, short-term assets of A$2.1 billion do not cover long-term liabilities of A$2.6 billion, posing potential risks amidst ongoing legal challenges related to historical advertising practices with Latitude Finance Australia, which Harvey Norman intends to defend vigorously in court.

Jump into the full analysis health report here for a deeper understanding of Harvey Norman Holdings. Gain insights into Harvey Norman Holdings' future direction by reviewing our growth report.ASX:HVN Financial Position Analysis as at Apr 2026

Judo Capital Holdings

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Judo Capital Holdings Limited, with a market cap of A$1.64 billion, provides a range of banking products and services specifically tailored for small and medium businesses in Australia through its subsidiaries.

Operations: The company's revenue is primarily derived from its Small and Medium Enterprises (SMEs) Lending segment, which generated A$380.9 million.

Market Cap: A$1.64B

Judo Capital Holdings Limited, with a market cap of A$1.64 billion, demonstrates robust financial performance in the SME lending sector. The company reported net interest income of A$235.5 million for H1 2026, reflecting significant growth from the previous year. Earnings grew by 62.4% over the past year, surpassing both its historical average and industry benchmarks. Despite this growth, Judo's return on equity remains low at 6.1%. The recent appointment of David Stephen to its board could enhance strategic direction given his extensive experience in risk management and compliance within banking and financial services sectors.

Take a closer look at Judo Capital Holdings' potential here in our financial health report. Gain insights into Judo Capital Holdings' outlook and expected performance with our report on the company's earnings estimates.ASX:JDO Financial Position Analysis as at Apr 2026

Summing It All Up

Get an in-depth perspective on all 391  ASX Penny Stocks by using our screener here. Searching for a Fresh Perspective? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:CGS ASX:HVN and ASX:JDO.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments